Cargando…

Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider

Immune checkpoint inhibitors (ICIs) are a revolutionary class of antineoplastic therapy that restore anti-tumor immunity. Consequences of this enhanced immune response include a multitude of immune related adverse events (irAEs) that can affect any body system, including the mouth. Orofacial irAEs r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Brittany A., Shazib, Muhammad Ali, Villa, Alessandro, de Abreu Alves, Fábio, Vacharotayangul, Piamkamon, Sonis, Stephen, Fedele, Stefano, Treister, Nathaniel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oral Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427772/ https://www.ncbi.nlm.nih.gov/pubmed/36060116 http://dx.doi.org/10.3389/froh.2022.968157

Ejemplares similares

Oral lichen planus: comparative efficacy and treatment costs—a systematic review
por: Sandhu, Shaiba, et al.
Publicado: (2022)

Oral manifestations, salivary flow rates and Candida species in Thai HIV-infected patients
por: Lam-ubol, Aroonwan, et al.
Publicado: (2019)

The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis
por: Adnan, Ather, et al.
Publicado: (2021)

Imaging orofacial pain in mice
por: Kim, Yu Shin, et al.
Publicado: (2014)

Editorial: Reviews in the neuroscience of orofacial functions
por: Christidis, Nikolaos, et al.
Publicado: (2023)

Study of chronic orofacial pain with preclinical models
por: ABD-Elsayed, Alaa, et al.
Publicado: (2014)

Editorial: Orofacial Pain of Muscular Origin—From Pathophysiology to Treatment
por: Christidis, Nikolaos, et al.
Publicado: (2022)

An Overview of Clinical Oncology and Impact on Oral Health
por: Harris, Jack A., et al.
Publicado: (2022)

Precision medicine for risk prediction of oral complications of cancer therapy–The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck
por: Sonis, Stephen T.
Publicado: (2022)

Orofacial pain : guidelines for assessment, diagnosis, and management /
Publicado: (2018)

A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse events
por: Sasikumar, Pottayil, et al.
Publicado: (2013)

The clinical relevance of microbiology specimens in orofacial abscesses of dental origin
por: Fowell, C, et al.
Publicado: (2012)

Clinical management of temporomandibular disorders and orofacial pain
Publicado: (1995)

Understanding patterns of adverse events after surgery and their impact on recovery
por: Nash, Rachel L, et al.
Publicado: (2015)

Sarcoidosis: comprehensive CMR evaluation and major adverse cardiac events
por: Higgins, Angela Y, et al.
Publicado: (2016)

Editorial: Oral complications in cancer patients
por: González-Arriagada, Wilfredo Alejandro, et al.
Publicado: (2023)

Prognostic value of dual T1 mapping to predict adverse events in TAVR-patients: extra cellular volume as a possible predictor for peri- and post-TAVR adverse events
por: Nadjiri, Jonathan, et al.
Publicado: (2016)

Safety and predictors of adverse events during oral immunotherapy with raw egg white
por: Vazquez-Ortiz, M, et al.
Publicado: (2013)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
por: Delaporta, P, et al.
Publicado: (2022)

P327 Prevalence of orofacial Mycoses in COVID-19patients: experience from a tertiary care center in Northern India
por: Agrawal, Sonu Kumari, et al.
Publicado: (2022)

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?
por: Romoli, Michele, et al.
Publicado: (2015)

Investigating the relationship between cancer and orofacial clefts using GWAS significant loci for cancers: A case-control and case-triad study
por: Fashina, Azeez, et al.
Publicado: (2022)

P043 Amphotericin B in pediatrics: analysis by age stratification suggests a greater chance of adverse events from 13-month of age onward
por: Cavassin, Francelise Bridi, et al.
Publicado: (2022)

Management of adverse events related to checkpoint inhibition therapy
por: Rudzki, Jakob Daniel
Publicado: (2018)

Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy
por: Vani, Vanina, et al.
Publicado: (2020)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors
por: Gujral, Dorothy M., et al.
Publicado: (2020)

OA12.01. Analysis of FDA mandated dietary supplement adverse event reports (AER) 2008-2009
por: Hardy, M, et al.
Publicado: (2012)

Incorporation of text recognition into trial it systems to safeguard against enrolment of ineligible patients or inappropriate reporting of adverse events
por: Dennis, Martin, et al.
Publicado: (2013)

Orofacial manifestations of adverse drug reactions: a review study
por: BAKHTIARI, SEDIGHEH, et al.
Publicado: (2018)

Orofacial adverse effects of COVID-19 vaccines exist but are rare
por: Sofi-Mahmudi, Ahmad
Publicado: (2021)

Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival
por: Villa-Crespo, Lorena, et al.
Publicado: (2022)

ANTENATAL EVENTS AMONGST MOTHERS OF BABIES WITH OROFACIAL CLEFTS
por: Olusanya, A.A., et al.
Publicado: (2020)

The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients
por: Stellbrink, HJ, et al.
Publicado: (2010)

O006 Major adverse cardiovascular events in severe Obstructive Sleep Apnoea: Associations with symptom subtypes and symptom burden
por: Shenoy, B, et al.
Publicado: (2023)

Healthcare professionals, substance use and adverse childhood experiences
por: Baklazec, Agnieszka, et al.
Publicado: (2015)

O015 Upper airway collapsibility measurement under anaesthesia in children: feasibility and utility in predicting perioperative respiratory adverse events
por: Ohn, M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mf7alnbiamve74vumpl5443tsu